Modeling the clinical and economic implications of obesity using microsimulation

Area of Science:

• Public Health
• Health Economics
• Biostatistics

Background:

• The rising obesity epidemic presents significant public health challenges.
• There is a need for validated longitudinal simulation models to assess the comprehensive impact of obesity.
• Understanding the interplay between body weight, health, and economic factors is crucial.

Purpose of the Study:

• To develop and present a microsimulation model for analyzing the relationship between body weight, health, and economic outcomes.
• To quantify the human and economic costs associated with obesity over a 10-year period.

Main Methods:

• A Markov-based microsimulation model was employed to simulate patient health and economic outcomes annually over 10 years.
• The model utilized nationally representative US data on obese adults and a matched normal-weight cohort.
• Prediction equations from published studies and original research informed simulations of comorbidities, expenditures, mortality, and quality-of-life.

Main Results:

• Obese adults incurred significantly higher medical expenditures compared to normal-weight individuals, increasing from $3900 in year one to $4600 by year ten.
• Obesity was associated with higher prevalence and earlier onset of comorbidities, increased absenteeism, mortality, and reduced employment and income.
• Annual excess medical costs attributed to obesity averaged $4280, with costs escalating with higher obesity categories and per kilogram of excess weight.

Conclusions:

• The validated model demonstrates that obese adults face higher medical and indirect costs than normal-weight adults.
• Medical costs for obese individuals increase more rapidly with age compared to their normal-weight counterparts.
• The model provides a comprehensive tool for understanding the multifaceted burden of obesity.